{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:25:55Z","timestamp":1768731955699,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T00:00:00Z","timestamp":1339113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme \u03b1-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. The incidence of disease is estimated at 1:40,000 in the general population, although neonatal screening initiatives have found an unexpectedly high prevalence of genetic alterations, up to 1:3,100, in newborns in Italy, and have identified a surprisingly high frequency of newborn males with genetic alterations (about 1:1,500) in Taiwan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We describe the case of a 40-year-old female patient who presented with transient ischemic attack (TIA), discomfort in her hands, intolerance to cold and heat, severe angina and palpitations, chronic kidney disease. Clinical, biochemical and molecular studies were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Reported symptoms, peculiar findings in a renal biopsy \u2013 the evidence of occasional lamellar inclusions in podocytes and mesangial cells \u2013 and left ventricular (LV) hypertrophy, which are considered to be specific features of FD, as well as molecular evaluations, suggested the diagnosis of a classical form of FD.<\/jats:p>\n            <jats:p>We detected four mutations in the GLA gene of the patient: -10C&gt;T (g.1170C&gt;T), c.370-77_-81del (g.7188-7192del5), c.640-16A&gt;G (g.10115A&gt;G), c.1000-22C&gt;T (g.10956C&gt;T). These mutations, located in promoter and intronic regulatory regions, have been observed in several patients with manifestations of FD. In our patient clinical picture showed a multisystemic involvement with early onset of symptoms, thus suggesting that these intronic mutations can be found even in patients with classical form of FD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2261-12-39","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T11:59:24Z","timestamp":1339588764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Antonio","family":"Pisani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Albeggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Iemolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,8]]},"reference":[{"issue":"2","key":"454_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman SC, Garboczi DN: The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004, 337 (2): 319-335. 10.1016\/j.jmb.2004.01.035.","journal-title":"J Mol Biol"},{"issue":"1","key":"454_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ: High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006, 79 (1): 31-40. 10.1086\/504601.","journal-title":"Am J Hum Genet"},{"issue":"10)","key":"454_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, Yeh HY, Chao MC, Lin SJ, Kitagawa T, Desnick RJ, Hsu LW: Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat. 2009, 30 (10)): 1397-1405.","journal-title":"Hum Mutat"},{"key":"454_CR4","first-page":"3733","volume-title":"The metabolic and molecular basis of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM: Alpha-Galactosidase A deficiency: Fabry disease. The metabolic and molecular basis of inherited disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. 2001, McGraw-Hill, New York, 3733-3774. 8","edition":"8"},{"issue":"8)","key":"454_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvorakova L, Ledvinova J, Magage S, Bultas J, Lubanda JC, Elleder M, Karetova D, Pavlikova M, Hrebicek M: Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med. 2005, 83 (8)): 647-654.","journal-title":"J Mol Med"},{"issue":"5","key":"454_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, Tanaka H: An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995, 333 (5): 288-293. 10.1056\/NEJM199508033330504.","journal-title":"N Engl J Med"},{"issue":"3","key":"454_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ: Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int. 2003, 64 (3): 801-807. 10.1046\/j.1523-1755.2003.00160.x.","journal-title":"Kidney Int"},{"key":"454_CR8","volume-title":"Fabry disease: Perspectives from 5 Years of FOS. Section3. Chapter 21","author":"G Sunder-Plassmann","year":"2006","unstructured":"Sunder-Plassmann G: Renal manifestations of Fabry disease. Fabry disease: Perspectives from 5 Years of FOS. Section3. Chapter 21. Edited by: Mehta A, Beck M, Sunder-Plassmann G. 2006, Oxford PharmaGenesis, Oxford"},{"issue":"3","key":"454_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2214\/AJR.05.0442","volume":"188","author":"M Imbriaco","year":"2007","unstructured":"Imbriaco M, Spinelli L, Cuocolo A, Maurea S, Sica G, Quarantelli M, Pisani A, Liuzzi R, Cianciaruso B, Sabbatini M, Salvatore M: MRI characterization of myocardial tissue in patients with Fabry\u2019s disease. AJR Am J Roentgenol. 2007, 188 (3): 850-853. 10.2214\/AJR.05.0442.","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"454_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","volume":"95","author":"M Imbriaco","year":"2009","unstructured":"Imbriaco M, Pisani A, Spinelli L, Cuocolo A, Messalli G, Capuano E, Marmo M, Liuzzi R, Visciano B, Cianciaruso B, Salvatore M: Effects of enzyme replacement therapy in patients with Anderson-Fabry disease: a prospective long term cardiac magnetic resonance imaging study. Heart. 2009, 95 (13): 1103-1107. 10.1136\/hrt.2008.162800.","journal-title":"Heart"},{"issue":"1","key":"454_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0002-9149(83)90093-0","volume":"52","author":"CB Higgins","year":"1983","unstructured":"Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, Crooks LE: Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983, 52 (1): 184-188. 10.1016\/0002-9149(83)90093-0.","journal-title":"Am J Cardiol"},{"issue":"1\u20132","key":"454_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","volume":"308","author":"NA Chamoles","year":"2001","unstructured":"Chamoles NA, Blanco M, Gaggioli D: Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta. 2001, 308 (1\u20132): 195-196.","journal-title":"Clin Chim Acta"},{"key":"454_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1756-0500-4-323","volume":"4","author":"C Bono","year":"2011","unstructured":"Bono C, Nuzzo D, Albeggiani G, Zizzo C, Francofonte D, Iemolo F, Sanzaro E, Duro G: Genetic screening of Fabry patients with EcoTILLING and HRM technology. BMC Res Notes. 2011, 4: 323-10.1186\/1756-0500-4-323.","journal-title":"BMC Res Notes"},{"issue":"Suppl 2","key":"454_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10545-008-0972-0","volume":"31","author":"JP Oliveira","year":"2008","unstructured":"Oliveira JP, Ferreira S, Reguenga C, Carvalho F, Mansson JE: The g.1170C>T polymorphism of the 5\u2019 untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression\u2014Evidence from a family study. J Inherit Metab Dis. 2008, 31 (Suppl 2): 405-413.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"454_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/jmg.30.8.658","volume":"30","author":"JP Davies","year":"1993","unstructured":"Davies JP, Winchester BG, Malcolm S: Sequence variations in the first exon of \u03b1-galactosidase A. Med Genet. 1993, 30 (8): 658-663. 10.1136\/jmg.30.8.658.","journal-title":"Med Genet"},{"issue":"3","key":"454_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.20144","volume":"25","author":"J Shabbeer","year":"2005","unstructured":"Shabbeer J, Robinson M, Desnick RJ: Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography. Hum Mutat. 2005, 25 (3): 299-305. 10.1002\/humu.20144.","journal-title":"Hum Mutat"},{"issue":"3","key":"454_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/humu.9172","volume":"22","author":"A Rodr\u00edguez-Mar\u00ed","year":"2003","unstructured":"Rodr\u00edguez-Mar\u00ed A, Coll MJ, Chab\u00e1s A: Molecular Analysis in Fabry Disease in Spain: Fifteen Novel GLA Mutations and Identification of a Homozygous Female. Hum Mutat. 2003, 22 (3): 258-","journal-title":"Hum Mutat"},{"issue":"4","key":"454_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1468-1331.2010.03227.x","volume":"18","author":"C Tanislav","year":"2011","unstructured":"Tanislav C, Kaps M, Rolfs A, B\u00f6ttcher T, Lackner K, Paschke E, Mascher H, Laue M, Blaes F: Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study. Eur J Neurol. 2011, 18 (4): 631-636. 10.1111\/j.1468-1331.2010.03227.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"454_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","volume":"70","author":"S Ishii","year":"2002","unstructured":"Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ: Alternative Splicing in the a-Galactosidase A Gene: Increased Exon Inclusion Results in the Fabry Cardiac Phenotype. Am J Hum Genet. 2002, 70 (4): 994-1002. 10.1086\/339431.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"454_CR20","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ejhg.2008.109","volume":"16","author":"C Filoni","year":"2008","unstructured":"Filoni C, Caciotti A, Carraresi L, Donati MA, Mignani R, Parini R, Filocamo M, Soliani F, Simi L, Guerrini R, Zammarchi E, Morrone A: Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. Eur J Hum Genet. 2008, 16 (11): 1311-1317. 10.1038\/ejhg.2008.109.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"454_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbadis.2008.09.017","volume":"1792","author":"J Tazi","year":"2009","unstructured":"Tazi J, Bakkour N, Stamm S: Alternative splicing and disease. Biochim Biophys Acta. 2009, 1792 (1): 14-26. 10.1016\/j.bbadis.2008.09.017.","journal-title":"Biochim Biophys Acta"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-12-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:36:52Z","timestamp":1630525012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-12-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-12-39","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,8]]},"assertion":[{"value":"20 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}